Table 1. Clinical characteristics.
Healthy control | HIV+/IR | HIV+/INR | P value (IR vs INR) | |
---|---|---|---|---|
Total no. of subjects | 12 | 13 | 11 | |
No. of male/female | 3 ⁄ 9 | 11 ⁄ 2 | 6 ⁄ 5 | 0.08 |
Age (yr) | 44 (34–58) | 43 (31–49) | 47 (36–56) | 0.21 |
Plasma HIV RNA | Not detectable | Not detectable | ||
CD4+ T cell counts | 782 (513–944) | 733 (658–777) | 322 (225–349) | < 0.0001 |
Years of ART | 15 (13.8–15.0) | 14 (11.0–16.0) | 0.46 | |
%CD38+HLA-DR+CD4+ | 1.17 (1.0–2.2) | 1.96 (1.2–3.2) | 0.09 | |
Nadir CD4+ T cell counts | 320 (215–507) | 170 (92–195) | 0.001 |
CD4+ T cell counts (cells/μl).
Plasma HIV RNA (copies/ml).
Data are medians (interquartile ranges).